<DOC>
	<DOCNO>NCT02448654</DOCNO>
	<brief_summary>The purpose study use medication tolcapone placebo test symptom nicotine withdrawal lessens , change smoke urge , mental reason female smoker 72 hour period .</brief_summary>
	<brief_title>Treatment Nicotine Addiction Women</brief_title>
	<detailed_description>The propose trail use double-blind , placebo-controlled design conduct first randomize control trial COMT inhibitor , tolcapone , nicotine dependent woman . This study determine tolcapone superior placebo attenuation severity nicotine withdrawal smoking urge short-term abstinence . Withdrawal severity assess self-report scale cognitive assessment , include sustained-attention task . Smoking urge assess self-report scale .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Tolcapone</mesh_term>
	<criteria>Must 18yrs 45yr old woman , read write English . Must smoke least 5 cigarette day FTND score least 4 high A CO read 10 high screening Must good health verify medical history , screen exam , screen laboratory test . Excluded use psychotropic medication , contraindication tolcapone use ( e.g.. liver problem , allergy tolcapone , history traumatic rhabdomyolysis hyperpyrexia , confusion possibly related medication ) , substance use disorder , pregnant breast feeding , current psychotic disorder , bipolar disorder , homicidal suicidal ideation , current ( past month ) substance use disorder , nicotine dependence , unable fulfill schedule visit procedure .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>